25 XP   0   0   10

Sartorius Stedim Biotech SA
Buy, Hold or Sell?

Let's analyse Sartorius together

PenkeI guess you are interested in Sartorius Stedim Biotech SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sartorius Stedim Biotech SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sartorius Stedim Biotech SA

I send you an email if I find something interesting about Sartorius Stedim Biotech SA.

Quick analysis of Sartorius (30 sec.)










What can you expect buying and holding a share of Sartorius? (30 sec.)

How much money do you get?

How much money do you get?
€1.45
When do you have the money?
1 year
How often do you get paid?
63.2%

What is your share worth?

Current worth
€27.47
Expected worth in 1 year
€29.10
How sure are you?
94.7%

+ What do you gain per year?

Total Gains per Share
€3.00
Return On Investment
1.5%

For what price can you sell your share?

Current Price per Share
€197.80
Expected price per share
€161.27 - €248.04
How sure are you?
50%

1. Valuation of Sartorius (5 min.)




Live pricePrice per Share (EOD)

€197.80

Intrinsic Value Per Share

€137.62 - €164.09

Total Value Per Share

€165.09 - €191.56

2. Growth of Sartorius (5 min.)




Is Sartorius growing?

Current yearPrevious yearGrowGrow %
How rich?$2.8b$2.3b$364.5m13.2%

How much money is Sartorius making?

Current yearPrevious yearGrowGrow %
Making money$82.5m$233.3m-$150.8m-182.9%
Net Profit Margin11.1%25.1%--

How much money comes from the company's main activities?

3. Financial Health of Sartorius (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#20 / 169

Most Revenue
#38 / 169

Most Profit
#29 / 169

What can you expect buying and holding a share of Sartorius? (5 min.)

Welcome investor! Sartorius's management wants to use your money to grow the business. In return you get a share of Sartorius.

What can you expect buying and holding a share of Sartorius?

First you should know what it really means to hold a share of Sartorius. And how you can make/lose money.

Speculation

The Price per Share of Sartorius is €197.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sartorius.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sartorius, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €27.47. Based on the TTM, the Book Value Change Per Share is €0.41 per quarter. Based on the YOY, the Book Value Change Per Share is €2.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.34 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sartorius.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.440.2%0.550.3%2.401.2%1.170.6%1.170.6%
Usd Book Value Change Per Share0.490.2%0.440.2%2.141.1%1.540.8%1.540.8%
Usd Dividend Per Share0.000.0%0.360.2%1.000.5%0.510.3%0.510.3%
Usd Total Gains Per Share0.490.2%0.800.4%3.141.6%2.051.0%2.051.0%
Usd Price Per Share254.89-257.29-345.20-302.22-302.22-
Price to Earnings Ratio146.22-156.88-36.26-151.18-151.18-
Price-to-Total Gains Ratio523.09-468.51-113.17-269.94-269.94-
Price to Book Ratio8.71-9.11-14.21-15.72-15.72-
Price-to-Total Gains Ratio523.09-468.51-113.17-269.94-269.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share210.77568
Number of shares4
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.360.51
Usd Book Value Change Per Share0.441.54
Usd Total Gains Per Share0.802.05
Gains per Quarter (4 shares)3.198.21
Gains per Year (4 shares)12.7832.82
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
167382523
2121416164956
3172129257489
42328423399122
529355541123155
635426849148188
741498157173221
846569465197254
9526310774222287
10587012082246320

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%16.02.01.084.2%16.02.01.084.2%16.02.01.084.2%
Dividend per Share1.00.03.025.0%7.00.05.058.3%12.00.07.063.2%12.00.07.063.2%12.00.07.063.2%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%18.00.01.094.7%18.00.01.094.7%18.00.01.094.7%

Fundamentals of Sartorius

About Sartorius Stedim Biotech SA

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

Fundamental data was last updated by Penke on 2024-04-18 05:18:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Sartorius Stedim Biotech SA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sartorius earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Sartorius to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 5.6% means that €0.06 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sartorius Stedim Biotech SA:

  • The MRQ is 5.6%. The company is making a profit. +1
  • The TTM is 11.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ5.6%TTM11.1%-5.5%
TTM11.1%YOY25.1%-14.0%
TTM11.1%5Y17.2%-6.1%
5Y17.2%10Y17.2%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6%6.2%-0.6%
TTM11.1%6.4%+4.7%
YOY25.1%8.0%+17.1%
5Y17.2%7.3%+9.9%
10Y17.2%6.8%+10.4%
1.1.2. Return on Assets

Shows how efficient Sartorius is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sartorius to the Medical Instruments & Supplies industry mean.
  • 0.5% Return on Assets means that Sartorius generated €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sartorius Stedim Biotech SA:

  • The MRQ is 0.5%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.5%TTM1.4%-0.9%
TTM1.4%YOY4.8%-3.4%
TTM1.4%5Y3.2%-1.8%
5Y3.2%10Y3.2%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5%1.3%-0.8%
TTM1.4%1.4%0.0%
YOY4.8%1.9%+2.9%
5Y3.2%2.1%+1.1%
10Y3.2%2.0%+1.2%
1.1.3. Return on Equity

Shows how efficient Sartorius is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sartorius to the Medical Instruments & Supplies industry mean.
  • 1.5% Return on Equity means Sartorius generated €0.02 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sartorius Stedim Biotech SA:

  • The MRQ is 1.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.5%TTM3.1%-1.6%
TTM3.1%YOY10.3%-7.2%
TTM3.1%5Y6.4%-3.3%
5Y6.4%10Y6.4%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5%2.6%-1.1%
TTM3.1%2.8%+0.3%
YOY10.3%3.7%+6.6%
5Y6.4%3.9%+2.5%
10Y6.4%3.9%+2.5%

1.2. Operating Efficiency of Sartorius Stedim Biotech SA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sartorius is operating .

  • Measures how much profit Sartorius makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sartorius to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sartorius Stedim Biotech SA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM8.2%-8.2%
TTM8.2%YOY31.9%-23.8%
TTM8.2%5Y24.8%-16.6%
5Y24.8%10Y24.8%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.9%-7.9%
TTM8.2%7.6%+0.6%
YOY31.9%10.9%+21.0%
5Y24.8%10.1%+14.7%
10Y24.8%10.5%+14.3%
1.2.2. Operating Ratio

Measures how efficient Sartorius is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.46 means that the operating costs are €1.46 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Sartorius Stedim Biotech SA:

  • The MRQ is 1.462. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.388. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.462TTM1.388+0.075
TTM1.388YOY1.165+0.223
TTM1.3885Y1.231+0.157
5Y1.23110Y1.2310.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4621.152+0.310
TTM1.3881.146+0.242
YOY1.1651.082+0.083
5Y1.2311.097+0.134
10Y1.2311.056+0.175

1.3. Liquidity of Sartorius Stedim Biotech SA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sartorius is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.51 means the company has €1.51 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Sartorius Stedim Biotech SA:

  • The MRQ is 1.510. The company is able to pay all its short-term debts. +1
  • The TTM is 1.620. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.510TTM1.620-0.110
TTM1.620YOY1.524+0.096
TTM1.6205Y1.560+0.060
5Y1.56010Y1.5600.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5102.310-0.800
TTM1.6202.339-0.719
YOY1.5242.575-1.051
5Y1.5602.627-1.067
10Y1.5602.623-1.063
1.3.2. Quick Ratio

Measures if Sartorius is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sartorius to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.31 means the company can pay off €0.31 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sartorius Stedim Biotech SA:

  • The MRQ is 0.313. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.358. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.313TTM0.358-0.045
TTM0.358YOY0.426-0.068
TTM0.3585Y0.462-0.104
5Y0.46210Y0.4620.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3131.105-0.792
TTM0.3581.137-0.779
YOY0.4261.306-0.880
5Y0.4621.430-0.968
10Y0.4621.533-1.071

1.4. Solvency of Sartorius Stedim Biotech SA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sartorius assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sartorius to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.65 means that Sartorius assets are financed with 65.5% credit (debt) and the remaining percentage (100% - 65.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sartorius Stedim Biotech SA:

  • The MRQ is 0.655. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.585. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.655TTM0.585+0.069
TTM0.585YOY0.519+0.066
TTM0.5855Y0.491+0.094
5Y0.49110Y0.4910.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6550.357+0.298
TTM0.5850.360+0.225
YOY0.5190.358+0.161
5Y0.4910.365+0.126
10Y0.4910.375+0.116
1.4.2. Debt to Equity Ratio

Measures if Sartorius is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sartorius to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 192.1% means that company has €1.92 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sartorius Stedim Biotech SA:

  • The MRQ is 1.921. The company is just able to pay all its debts with equity.
  • The TTM is 1.518. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.921TTM1.518+0.403
TTM1.518YOY1.117+0.401
TTM1.5185Y1.061+0.457
5Y1.06110Y1.0610.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9210.541+1.380
TTM1.5180.561+0.957
YOY1.1170.561+0.556
5Y1.0610.648+0.413
10Y1.0610.669+0.392

2. Market Valuation of Sartorius Stedim Biotech SA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Sartorius generates.

  • Above 15 is considered overpriced but always compare Sartorius to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 146.22 means the investor is paying €146.22 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sartorius Stedim Biotech SA:

  • The EOD is 120.909. Based on the earnings, the company is expensive. -2
  • The MRQ is 146.216. Based on the earnings, the company is expensive. -2
  • The TTM is 156.883. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD120.909MRQ146.216-25.307
MRQ146.216TTM156.883-10.667
TTM156.883YOY36.265+120.619
TTM156.8835Y151.177+5.706
5Y151.17710Y151.1770.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD120.90914.579+106.330
MRQ146.21616.584+129.632
TTM156.88317.443+139.440
YOY36.26522.147+14.118
5Y151.17720.830+130.347
10Y151.17725.069+126.108
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sartorius Stedim Biotech SA:

  • The EOD is 20.635. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 24.954. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 4,413.783. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD20.635MRQ24.954-4.319
MRQ24.954TTM4,413.783-4,388.828
TTM4,413.783YOY28.942+4,384.841
TTM4,413.7835Y1,023.278+3,390.505
5Y1,023.27810Y1,023.2780.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD20.6359.822+10.813
MRQ24.95410.068+14.886
TTM4,413.7831.387+4,412.396
YOY28.9423.453+25.489
5Y1,023.2785.897+1,017.381
10Y1,023.278-0.177+1,023.455
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sartorius is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 8.71 means the investor is paying €8.71 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Sartorius Stedim Biotech SA:

  • The EOD is 7.201. Based on the equity, the company is overpriced. -1
  • The MRQ is 8.708. Based on the equity, the company is overpriced. -1
  • The TTM is 9.109. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.201MRQ8.708-1.507
MRQ8.708TTM9.109-0.401
TTM9.109YOY14.211-5.102
TTM9.1095Y15.725-6.616
5Y15.72510Y15.7250.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD7.2012.398+4.803
MRQ8.7082.753+5.955
TTM9.1092.690+6.419
YOY14.2113.294+10.917
5Y15.7253.563+12.162
10Y15.7254.227+11.498
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sartorius Stedim Biotech SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4570.408+12%2.006-77%1.446-68%1.446-68%
Book Value Per Share--27.47026.612+3%23.097+19%18.866+46%18.866+46%
Current Ratio--1.5101.620-7%1.524-1%1.560-3%1.560-3%
Debt To Asset Ratio--0.6550.585+12%0.519+26%0.491+33%0.491+33%
Debt To Equity Ratio--1.9211.518+27%1.117+72%1.061+81%1.061+81%
Dividend Per Share---0.341-100%0.937-100%0.479-100%0.479-100%
Eps--0.4090.520-21%2.251-82%1.098-63%1.098-63%
Free Cash Flow Per Share--2.3960.701+242%0.467+413%0.840+185%0.840+185%
Free Cash Flow To Equity Per Share--2.39611.967-80%1.034+132%3.419-30%3.419-30%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--164.087--------
Intrinsic Value_10Y_min--137.619--------
Intrinsic Value_1Y_max--5.758--------
Intrinsic Value_1Y_min--5.650--------
Intrinsic Value_3Y_max--25.444--------
Intrinsic Value_3Y_min--24.127--------
Intrinsic Value_5Y_max--54.947--------
Intrinsic Value_5Y_min--50.300--------
Market Cap19248748760.000-21%23277556640.00023496513590.000-1%31524935090.000-26%27599331480.000-16%27599331480.000-16%
Net Profit Margin--0.0560.111-49%0.251-78%0.172-67%0.172-67%
Operating Margin---0.082-100%0.319-100%0.248-100%0.248-100%
Operating Ratio--1.4621.388+5%1.165+26%1.231+19%1.231+19%
Pb Ratio7.201-21%8.7089.109-4%14.211-39%15.725-45%15.725-45%
Pe Ratio120.909-21%146.216156.883-7%36.265+303%151.177-3%151.177-3%
Price Per Share197.800-21%239.200241.450-1%323.950-26%283.611-16%283.611-16%
Price To Free Cash Flow Ratio20.635-21%24.9544413.783-99%28.942-14%1023.278-98%1023.278-98%
Price To Total Gains Ratio432.556-21%523.091468.508+12%113.172+362%269.942+94%269.942+94%
Quick Ratio--0.3130.358-13%0.426-26%0.462-32%0.462-32%
Return On Assets--0.0050.014-63%0.048-89%0.032-84%0.032-84%
Return On Equity--0.0150.031-51%0.103-85%0.064-76%0.064-76%
Total Gains Per Share--0.4570.749-39%2.944-84%1.925-76%1.925-76%
Usd Book Value--2848561920.0002759637600.000+3%2395095840.000+19%1956322308.884+46%1956322308.884+46%
Usd Book Value Change Per Share--0.4870.435+12%2.138-77%1.541-68%1.541-68%
Usd Book Value Per Share--29.27228.358+3%24.612+19%20.103+46%20.103+46%
Usd Dividend Per Share---0.363-100%0.999-100%0.511-100%0.511-100%
Usd Eps--0.4360.554-21%2.398-82%1.170-63%1.170-63%
Usd Free Cash Flow--248497920.00072673920.000+242%48404880.000+413%87071522.021+185%87071522.021+185%
Usd Free Cash Flow Per Share--2.5540.747+242%0.497+413%0.895+185%0.895+185%
Usd Free Cash Flow To Equity Per Share--2.55412.752-80%1.102+132%3.643-30%3.643-30%
Usd Market Cap20511466678.656-21%24804564355.58425037884881.504-1%33592970831.904-26%29409847625.088-16%29409847625.088-16%
Usd Price Per Share210.776-21%254.892257.289-1%345.201-26%302.215-16%302.215-16%
Usd Profit--42410880.00082504080.000-49%233393040.000-82%119859585.347-65%119859585.347-65%
Usd Revenue--753166080.000739393200.000+2%930455280.000-19%682159431.411+10%682159431.411+10%
Usd Total Gains Per Share--0.4870.799-39%3.137-84%2.052-76%2.052-76%
 EOD+4 -4MRQTTM+14 -21YOY+12 -235Y+12 -2310Y+12 -23

3.2. Fundamental Score

Let's check the fundamental score of Sartorius Stedim Biotech SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15120.909
Price to Book Ratio (EOD)Between0-17.201
Net Profit Margin (MRQ)Greater than00.056
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.313
Current Ratio (MRQ)Greater than11.510
Debt to Asset Ratio (MRQ)Less than10.655
Debt to Equity Ratio (MRQ)Less than11.921
Return on Equity (MRQ)Greater than0.150.015
Return on Assets (MRQ)Greater than0.050.005
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Sartorius Stedim Biotech SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose197.800
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets7,739,900
Total Liabilities5,066,700
Total Stockholder Equity2,637,900
 As reported
Total Liabilities 5,066,700
Total Stockholder Equity+ 2,637,900
Total Assets = 7,739,900

Assets

Total Assets7,739,900
Total Current Assets1,415,100
Long-term Assets6,324,800
Total Current Assets
Cash And Cash Equivalents 116,600
Net Receivables 293,800
Inventory 882,400
Other Current Assets 66,000
Total Current Assets  (as reported)1,415,100
Total Current Assets  (calculated)1,358,800
+/- 56,300
Long-term Assets
Property Plant Equipment 1,633,300
Goodwill 2,851,900
Intangible Assets 1,736,200
Long-term Assets Other 2,700
Long-term Assets  (as reported)6,324,800
Long-term Assets  (calculated)6,224,100
+/- 100,700

Liabilities & Shareholders' Equity

Total Current Liabilities937,300
Long-term Liabilities4,129,400
Total Stockholder Equity2,637,900
Total Current Liabilities
Short Long Term Debt 57,700
Accounts payable 257,100
Other Current Liabilities 103,100
Total Current Liabilities  (as reported)937,300
Total Current Liabilities  (calculated)417,900
+/- 519,400
Long-term Liabilities
Long term Debt 3,509,800
Capital Lease Obligations Min Short Term Debt114,500
Long-term Liabilities  (as reported)4,129,400
Long-term Liabilities  (calculated)3,624,300
+/- 505,100
Total Stockholder Equity
Retained Earnings 2,388,000
Total Stockholder Equity (as reported)2,637,900
Total Stockholder Equity (calculated)2,388,000
+/- 249,900
Other
Capital Stock18,400
Common Stock Shares Outstanding 92,165
Net Debt 3,450,900
Net Invested Capital 6,205,400
Net Working Capital 477,800
Property Plant and Equipment Gross 2,175,700



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
0
1,693,800
0
1,820,421
1,895,400
2,224,100
2,361,500
3,069,336
3,313,000
3,521,900
3,976,100
3,951,098
4,158,700
4,375,100
5,097,100
5,065,400
5,096,700
5,187,200
7,958,900
7,739,900
7,739,9007,958,9005,187,2005,096,7005,065,4005,097,1004,375,1004,158,7003,951,0983,976,1003,521,9003,313,0003,069,3362,361,5002,224,1001,895,4001,820,42101,693,8000
   > Total Current Assets 
0
609,100
652,700
633,802
704,300
816,800
961,100
875,216
1,061,800
1,252,000
1,387,800
1,455,629
1,563,300
1,697,100
1,780,900
1,671,200
1,646,200
1,618,000
1,525,000
1,415,100
1,415,1001,525,0001,618,0001,646,2001,671,2001,780,9001,697,1001,563,3001,455,6291,387,8001,252,0001,061,800875,216961,100816,800704,300633,802652,700609,1000
       Cash And Cash Equivalents 
0
25,500
0
27,643
69,900
89,300
165,900
59,762
149,400
254,700
226,800
223,626
165,100
156,100
145,500
107,100
94,000
110,000
99,300
116,600
116,60099,300110,00094,000107,100145,500156,100165,100223,626226,800254,700149,40059,762165,90089,30069,90027,643025,5000
       Short-term Investments 
0
9,900
0
18,297
48,700
0
65,500
9,843
15,200
0
9,700
13,721
47,100
24,900
16,200
25,900
19,000
14,300
19,400
0
019,40014,30019,00025,90016,20024,90047,10013,7219,700015,2009,84365,500048,70018,29709,9000
       Net Receivables 
0
247,400
266,100
242,188
215,300
232,100
253,300
263,962
310,500
320,300
368,300
371,716
417,100
455,200
467,700
419,700
387,900
310,500
333,900
293,800
293,800333,900310,500387,900419,700467,700455,200417,100371,716368,300320,300310,500263,962253,300232,100215,300242,188266,100247,4000
       Other Current Assets 
0
30,900
26,300
27,901
29,900
37,800
38,900
69,344
51,900
59,000
88,800
64,583
76,500
96,800
92,900
94,800
84,400
101,800
80,400
66,000
66,00080,400101,80084,40094,80092,90096,80076,50064,58388,80059,00051,90069,34438,90037,80029,90027,90126,30030,9000
   > Long-term Assets 
0
1,084,600
0
1,186,619
1,191,100
1,407,300
1,400,300
2,194,120
2,251,200
2,269,900
2,588,300
2,495,469
2,595,400
2,678,100
3,316,300
3,394,200
3,450,400
3,569,200
6,433,900
6,324,800
6,324,8006,433,9003,569,2003,450,4003,394,2003,316,3002,678,1002,595,4002,495,4692,588,3002,269,9002,251,2002,194,1201,400,3001,407,3001,191,1001,186,61901,084,6000
       Property Plant Equipment 
485,900
498,700
524,600
466,754
549,600
561,700
566,400
518,278
693,800
726,000
799,800
640,242
986,600
1,066,700
1,193,400
1,292,200
1,355,300
1,455,200
1,564,200
1,633,300
1,633,3001,564,2001,455,2001,355,3001,292,2001,193,4001,066,700986,600640,242799,800726,000693,800518,278566,400561,700549,600466,754524,600498,700485,900
       Goodwill 
0
383,300
0
426,890
423,100
463,100
459,000
875,162
880,100
866,800
934,700
820,702
832,400
836,100
1,125,200
1,136,400
1,135,300
1,150,000
2,319,900
2,851,900
2,851,9002,319,9001,150,0001,135,3001,136,4001,125,200836,100832,400820,702934,700866,800880,100875,162459,000463,100423,100426,8900383,3000
       Intangible Assets 
0
179,500
0
180,091
182,000
347,400
338,800
633,521
632,300
631,600
805,500
684,416
705,300
699,100
917,300
876,900
870,600
879,400
2,453,900
1,736,200
1,736,2002,453,900879,400870,600876,900917,300699,100705,300684,416805,500631,600632,300633,521338,800347,400182,000180,0910179,5000
       Long-term Assets Other 
0
700
0
584
700
600
700
509
500
600
500
654
600
600
700
2,200
2,400
2,800
2,400
2,700
2,7002,4002,8002,4002,20070060060065450060050050970060070058407000
> Total Liabilities 
0
586,600
0
642,792
649,500
936,200
983,900
1,586,419
1,756,800
1,828,800
2,212,700
2,217,871
2,159,100
2,247,700
2,747,700
2,551,200
2,642,300
2,584,500
5,330,200
5,066,700
5,066,7005,330,2002,584,5002,642,3002,551,2002,747,7002,247,7002,159,1002,217,8712,212,7001,828,8001,756,8001,586,419983,900936,200649,500642,7920586,6000
   > Total Current Liabilities 
0
416,200
424,800
427,345
433,700
493,100
536,700
567,693
708,000
792,400
938,600
1,037,119
1,025,400
1,158,200
1,192,300
1,035,900
1,151,500
922,000
853,600
937,300
937,300853,600922,0001,151,5001,035,9001,192,3001,158,2001,025,4001,037,119938,600792,400708,000567,693536,700493,100433,700427,345424,800416,2000
       Short-term Debt 
0
79,700
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000079,7000
       Short Long Term Debt 
0
79,700
0
43,545
25,900
22,500
18,800
13,112
27,600
26,400
50,600
25,505
27,700
130,700
57,400
4,400
174,900
7,000
11,900
57,700
57,70011,9007,000174,9004,40057,400130,70027,70025,50550,60026,40027,60013,11218,80022,50025,90043,545079,7000
       Accounts payable 
0
173,200
195,700
115,999
199,100
222,100
239,000
174,733
364,600
407,400
439,800
251,361
506,000
520,800
520,300
251,500
454,900
440,400
412,100
257,100
257,100412,100440,400454,900251,500520,300520,800506,000251,361439,800407,400364,600174,733239,000222,100199,100115,999195,700173,2000
       Other Current Liabilities 
0
41,100
121,700
216,080
161,100
183,300
202,000
309,222
240,500
258,800
322,700
648,155
395,600
412,500
493,700
686,300
410,700
94,100
316,500
103,100
103,100316,50094,100410,700686,300493,700412,500395,600648,155322,700258,800240,500309,222202,000183,300161,100216,080121,70041,1000
   > Long-term Liabilities 
0
170,400
0
215,447
215,800
443,300
447,200
1,018,726
1,048,800
1,036,400
1,274,100
1,180,752
1,133,700
1,089,500
1,555,400
1,515,300
1,490,800
1,662,500
4,476,600
4,129,400
4,129,4004,476,6001,662,5001,490,8001,515,3001,555,4001,089,5001,133,7001,180,7521,274,1001,036,4001,048,8001,018,726447,200443,300215,800215,4470170,4000
       Capital Lease Obligations Min Short Term Debt
0
-30,600
0
51,799
50,200
54,700
56,400
58,015
66,200
68,100
70,000
78,939
81,900
80,400
87,300
110,600
111,600
110,000
120,100
114,500
114,500120,100110,000111,600110,60087,30080,40081,90078,93970,00068,10066,20058,01556,40054,70050,20051,7990-30,6000
       Long-term Liabilities Other 
0
0
0
-1
0
100
100
0
0
100
-100
0
0
0
0
100
100
0
100
0
010001001000000-100100001001000-1000
       Deferred Long Term Liability 
0
0
0
83,785
0
0
0
101,042
0
0
0
120,922
0
0
0
164,200
0
0
0
0
0000164,200000120,922000101,04200083,785000
> Total Stockholder Equity
0
1,099,200
0
1,158,789
1,226,800
1,258,900
1,347,200
1,460,041
1,530,900
1,668,500
1,668,300
1,655,866
1,923,100
2,051,500
2,272,800
2,449,300
2,420,300
2,569,200
2,594,600
2,637,900
2,637,9002,594,6002,569,2002,420,3002,449,3002,272,8002,051,5001,923,1001,655,8661,668,3001,668,5001,530,9001,460,0411,347,2001,258,9001,226,8001,158,78901,099,2000
   Common Stock
18,400
18,400
18,400
18,436
18,400
18,400
18,400
18,436
18,400
18,400
18,400
18,436
18,400
18,400
18,400
18,400
18,400
0
18,400
0
018,400018,40018,40018,40018,40018,40018,43618,40018,40018,40018,43618,40018,40018,40018,43618,40018,40018,400
   Retained Earnings Total Equity00000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
231,500
234,000
231,500
240,895
231,500
231,200
231,500
210,415
231,600
224,000
231,500
251,809
231,600
282,500
231,500
251,900
231,500
246,700
231,500
0
0231,500246,700231,500251,900231,500282,500231,600251,809231,500224,000231,600210,415231,500231,200231,500240,895231,500234,000231,500



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,775,500
Cost of Revenue-1,542,000
Gross Profit1,233,5001,233,500
 
Operating Income (+$)
Gross Profit1,233,500
Operating Expense-2,305,000
Operating Income470,500-1,071,500
 
Operating Expense (+$)
Research Development129,500
Selling General Administrative616,200
Selling And Marketing Expenses0
Operating Expense2,305,000745,700
 
Net Interest Income (+$)
Interest Income6,200
Interest Expense-117,000
Other Finance Cost-11,800
Net Interest Income-122,600
 
Pretax Income (+$)
Operating Income470,500
Net Interest Income-122,600
Other Non-Operating Income Expenses0
Income Before Tax (EBT)401,100470,500
EBIT - interestExpense = -117,000
309,700
426,700
Interest Expense117,000
Earnings Before Interest and Taxes (EBIT)0518,100
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax401,100
Tax Provision-89,000
Net Income From Continuing Ops312,100312,100
Net Income309,700
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0122,600
 

Technical Analysis of Sartorius
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sartorius. The general trend of Sartorius is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sartorius's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sartorius Stedim Biotech SA.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 220.22 < 240.46 < 248.04.

The bearish price targets are: 195.98 > 194.88 > 161.27.

Tweet this
Sartorius Stedim Biotech SA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sartorius Stedim Biotech SA. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sartorius Stedim Biotech SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sartorius Stedim Biotech SA.

Sartorius Stedim Biotech SA Daily Moving Average Convergence/Divergence (MACD) ChartSartorius Stedim Biotech SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sartorius Stedim Biotech SA. The current adx is .

Sartorius Stedim Biotech SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sartorius Stedim Biotech SA.

Sartorius Stedim Biotech SA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sartorius Stedim Biotech SA.

Sartorius Stedim Biotech SA Daily Relative Strength Index (RSI) ChartSartorius Stedim Biotech SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sartorius Stedim Biotech SA.

Sartorius Stedim Biotech SA Daily Stochastic Oscillator ChartSartorius Stedim Biotech SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sartorius Stedim Biotech SA.

Sartorius Stedim Biotech SA Daily Commodity Channel Index (CCI) ChartSartorius Stedim Biotech SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sartorius Stedim Biotech SA.

Sartorius Stedim Biotech SA Daily Chande Momentum Oscillator (CMO) ChartSartorius Stedim Biotech SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sartorius Stedim Biotech SA.

Sartorius Stedim Biotech SA Daily Williams %R ChartSartorius Stedim Biotech SA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sartorius Stedim Biotech SA.

Sartorius Stedim Biotech SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sartorius Stedim Biotech SA.

Sartorius Stedim Biotech SA Daily Average True Range (ATR) ChartSartorius Stedim Biotech SA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sartorius Stedim Biotech SA.

Sartorius Stedim Biotech SA Daily On-Balance Volume (OBV) ChartSartorius Stedim Biotech SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sartorius Stedim Biotech SA.

Sartorius Stedim Biotech SA Daily Money Flow Index (MFI) ChartSartorius Stedim Biotech SA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sartorius Stedim Biotech SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-05 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-07 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-11 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-08 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-09 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-14 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-16 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-07 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-08 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-10 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-15 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Sartorius Stedim Biotech SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sartorius Stedim Biotech SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose197.800
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sartorius with someone you think should read this too:
  • Are you bullish or bearish on Sartorius? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sartorius? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sartorius Stedim Biotech SA

I send you an email if I find something interesting about Sartorius Stedim Biotech SA.


Comments

How you think about this?

Leave a comment

Stay informed about Sartorius Stedim Biotech SA.

Receive notifications about Sartorius Stedim Biotech SA in your mailbox!